Lipid uptake in chronic lymphocytic leukemia

Research output: Contribution to journalArticlepeer-review

Abstract

Many cancers rely on glucose as an energy source, but it is becoming increasingly apparent that some cancers use alternate substrates to fuel their proliferation. Chronic lymphocytic leukaemia (CLL) is one such cancer. Through the use of flow cytometry and confocal microscopy, low levels of glucose uptake were observed in the OSU-CLL and HG3 CLL cell lines relative to highly glucose-avid Raji cells (Burkitt's lymphoma). Glucose uptake in CLL cells correlated with low expression of the GLUT1 and GLUT3 receptors. In contrast, both CLL cell lines and primary CLL cells, but not healthy B cells, were found to rapidly internalise medium- and long-chain, but not short-chain, fatty acids (FAs). Differential FA uptake was also observed in primary cells taken from patients with unmutated immunoglobulin heavy variable chain usage (IGHV) compared with patients with mutated IGHV. Delipidation of serum in the culture medium slowed the proliferation and significantly reduced the viability of OSU-CLL and HG3 cells, effects that were partially reversed by supplementation with a chemically defined lipid concentrate. These observations highlight the potential importance of FAs in the pathogenesis of CLL and raise the possibility that targeting FA utilisation may represent a novel therapeutic and prognostic approach in this disease.

Original languageEnglish
Pages (from-to)58-67
Number of pages10
JournalExperimental Hematology
Volume106
DOIs
Publication statusPublished - Feb 2022

Keywords

  • lipid uptake
  • chronic lymphocytic leukemia
  • flow cytometry
  • confocal microscopy
  • glucose-avid Raji cells
  • glucose uptake
  • fatty acid

Fingerprint

Dive into the research topics of 'Lipid uptake in chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Cite this